Fish-oil dietary supplementation in patients with Raynaud's phenomenon: A double-blind, controlled, prospective study

This publication has 23 references indexed in Scilit:

• Prevalence of Raynaud phenomenon in the general population: A preliminary study by questionnaire
  Published by Elsevier ,2004
• Cardiovascular Effects of n-3 Fatty Acids
  New England Journal of Medicine, 1988
• Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil Function
  New England Journal of Medicine, 1985
• Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin₂ (5‐HT₂) receptor
  Arthritis & Rheumatism, 1984
• Interleukin-1
  Clinical Infectious Diseases, 1984
• Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5ω3)
  Biochemical and Biophysical Research Communications, 1983
• Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's Phenomenon
  New England Journal of Medicine, 1983
• Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil.
  Circulation, 1983
• Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects
  Atherosclerosis, 1983
• Cold Hypersensitivity in Raynaud's Phenomenon
  Circulation, 1971